| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Pathology and Molecular Medicine and Division of Infectious Diseases, Center for Gene Therapeutics, McMaster University, Hamilton, Ontario, Canada
The mechanisms underlying better immune protection by mucosal vaccination have remained poorly understood. In our current study we have investigated the mechanisms by which respiratory virus-mediated mucosal vaccination provides remarkably better immune protection against pulmonary tuberculosis than parenteral vaccination. A recombinant adenovirus-based tuberculosis (TB) vaccine expressing Mycobacterium tuberculosis Ag85A (AdAg85A) was administered either intranasally (i.n.) or i.m. to mice, and Ag-specific CD4 and CD8 T cell responses, including frequency, IFN-
production, and CTL, were examined in the spleen, lung interstitium, and airway lumen. Although i.m. immunization with AdAg85A led to activation of T cells, particularly CD8 T cells, in the spleen and, to a lesser extent, in the lung interstitium, it failed to elicit any T cell response in the airway lumen. In contrast, although i.n. immunization failed to effectively activate T cells in the spleen, it uniquely elicited higher numbers of Ag-specific CD4 and CD8 T cells in the airway lumen that were capable of IFN- production and cytolytic activities, as assessed by an intratracheal in vivo CTL assay. These airway luminal T cells of i.n. immunized mice or splenic T cells of i.m. immunized mice, upon transfer locally to the lungs of naive SCID mice, conferred immune protection against M. tuberculosis challenge. Our study has demonstrated that the airway luminal T cell population plays an important role in immune protection against pulmonary TB, thus providing mechanistic insights into the superior immune protection conferred by respiratory mucosal TB vaccination.
This article has been cited by other articles:
|
|
 |
|
  I. M. Belyakov and J. D. Ahlers What Role Does the Route of Immunization Play in the Generation of Protective Immunity against Mucosal Pathogens? J. Immunol., December 1, 2009; 183(11): 6883 - 6892. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Ozawa, T. Suda, T. Nagata, D. Hashimoto, Y. Nakamura, N. Enomoto, N. Inui, Y. Koide, H. Nakamura, and K. Chida Mucosal Vaccine Using CTL Epitope-Pulsed Dendritic Cell Confers Protection for Intracellular Pathogen Am. J. Respir. Cell Mol. Biol., October 1, 2009; 41(4): 440 - 448. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Kaufman and D. H. Barouch Response to Comment on "Trafficking of Antigen-Specific CD8+ T Lymphocytes to Mucosal Surfaces following Intramuscular Vaccination" J. Immunol., February 15, 2009; 182(4): 1779 - 1780. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ciabattini, E. Pettini, P. Andersen, G. Pozzi, and D. Medaglini Primary Activation of Antigen-Specific Naive CD4+ and CD8+ T Cells following Intranasal Vaccination with Recombinant Bacteria Infect. Immun., December 1, 2008; 76(12): 5817 - 5825. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Jeyanathan, J. Mu, K. Kugathasan, X. Zhang, D. Damjanovic, C. Small, M. Divangahi, B. J. Petrof, C. M. Hogaboam, and Z. Xing Airway Delivery of Soluble Mycobacterial Antigens Restores Protective Mucosal Immunity by Single Intramuscular Plasmid DNA Tuberculosis Vaccination: Role of Proinflammatory Signals in the Lung J. Immunol., October 15, 2008; 181(8): 5618 - 5626. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. K. Forbes, C. Sander, E. O. Ronan, H. McShane, A. V. S. Hill, P. C. L. Beverley, and E. Z. Tchilian Multifunctional, High-Level Cytokine-Producing Th1 Cells in the Lung, but Not Spleen, Correlate with Protection against Mycobacterium tuberculosis Aerosol Challenge in Mice J. Immunol., October 1, 2008; 181(7): 4955 - 4964. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Kaufman, J. Liu, A. Carville, K. G. Mansfield, M. J. E. Havenga, J. Goudsmit, and D. H. Barouch Trafficking of Antigen-Specific CD8+ T Lymphocytes to Mucosal Surfaces following Intramuscular Vaccination J. Immunol., September 15, 2008; 181(6): 4188 - 4198. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. McCormick, M. Santosuosso, C.-L. Small, C. R. Shaler, X. Zhang, M. Jeyanathan, J. Mu, S. Takenaka, P. Ngai, J. Gauldie, et al. Mucosally Delivered Dendritic Cells Activate T Cells Independently of IL-12 and Endogenous APCs J. Immunol., August 15, 2008; 181(4): 2356 - 2367. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Rodriguez, J. Goudsmit, A. Companjen, R. Mintardjo, G. Gillissen, D. Tax, J. Sijtsma, G. J. Weverling, L. Holterman, D. E. Lanar, et al. Impact of Recombinant Adenovirus Serotype 35 Priming versus Boosting of a Plasmodium falciparum Protein: Characterization of T- and B-Cell Responses to Liver-Stage Antigen 1 Infect. Immun., April 1, 2008; 76(4): 1709 - 1718. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Li, M. Zhang, C. Zhou, X. Zhao, N. Iijima, and F. R. Frankel Novel Vaccination Protocol with Two Live Mucosal Vectors Elicits Strong Cell-Mediated Immunity in the Vagina and Protects against Vaginal Virus Challenge J. Immunol., February 15, 2008; 180(4): 2504 - 2513. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Divangahi, T. Yang, K. Kugathasan, S. McCormick, S. Takenaka, G. Gaschler, A. Ashkar, M. Stampfli, J. Gauldie, J. Bramson, et al. Critical Negative Regulation of Type 1 T Cell Immunity and Immunopathology by Signaling Adaptor DAP12 during Intracellular Infection J. Immunol., September 15, 2007; 179(6): 4015 - 4026. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Santosuosso, S. McCormick, E. Roediger, X. Zhang, A. Zganiacz, B. D. Lichty, and Z. Xing Mucosal Luminal Manipulation of T Cell Geography Switches on Protective Efficacy by Otherwise Ineffective Parenteral Genetic Immunization J. Immunol., February 15, 2007; 178(4): 2387 - 2395. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. S. Andersen, J. Dietrich, E. M. Agger, N. Y. Lycke, K. Lovgren, and P. Andersen The Combined CTA1-DD/ISCOMs Vector Is an Effective Intranasal Adjuvant for Boosting Prior Mycobacterium bovis BCG Immunity to Mycobacterium tuberculosis Infect. Immun., January 1, 2007; 75(1): 408 - 416. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-Q. Xin, H. Mizukami, M. Urabe, Y. Toda, K. Shinoda, A. Yoshida, K. Oomura, Y. Kojima, M. Ichino, D. Klinman, et al. Induction of Robust Immune Responses against Human Immunodeficiency Virus Is Supported by the Inherent Tropism of Adeno-Associated Virus Type 5 for Dendritic Cells J. Virol., December 15, 2006; 80(24): 11899 - 11910. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Dietrich, C. Andersen, R. Rappuoli, T. M. Doherty, C. G. Jensen, and P. Andersen Mucosal Administration of Ag85B-ESAT-6 Protects against Infection with Mycobacterium tuberculosis and Boosts Prior Bacillus Calmette-Guerin Immunity J. Immunol., November 1, 2006; 177(9): 6353 - 6360. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Santosuosso, S. McCormick, X. Zhang, A. Zganiacz, and Z. Xing Intranasal Boosting with an Adenovirus-Vectored Vaccine Markedly Enhances Protection by Parenteral Mycobacterium bovis BCG Immunization against Pulmonary Tuberculosis. Infect. Immun., August 1, 2006; 74(8): 4634 - 4643. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. M. Vordermeier, K. Huygen, M. Singh, R. G. Hewinson, and Z. Xing Immune Responses Induced in Cattle by Vaccination with a Recombinant Adenovirus Expressing Mycobacterial Antigen 85A and Mycobacterium bovis BCG Infect. Immun., February 1, 2006; 74(2): 1416 - 1418. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
